Latha Soorya to Child
This is a "connection" page, showing publications Latha Soorya has written about Child.
Connection Strength
0.739
-
Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2021 09; 31(7):475-484.
Score: 0.142
-
Randomized comparative trial of a social cognitive skills group for children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2015 Mar; 54(3):208-216.e1.
Score: 0.089
-
Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2008 Oct; 17(4):753-71, viii.
Score: 0.058
-
Social cognitive skills groups increase medial prefrontal cortex activity in children with autism spectrum disorder. Autism Res. 2021 12; 14(12):2495-2511.
Score: 0.035
-
Psychometric Study of the Social Responsiveness Scale in Phelan-McDermid Syndrome. Autism Res. 2020 08; 13(8):1383-1396.
Score: 0.032
-
Diffusion Tensor Imaging Abnormalities in the Uncinate Fasciculus and Inferior Longitudinal Fasciculus in Phelan-McDermid Syndrome. Pediatr Neurol. 2020 05; 106:24-31.
Score: 0.032
-
Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid Syndrome. Pediatr Neurol. 2019 01; 90:37-43.
Score: 0.029
-
A Multisite, Multidisciplinary Delphi Consensus Study Describing "Usual Care" Intervention Strategies for School-Age to Transition-Age Youth With Autism. J Clin Child Adolesc Psychol. 2019; 48(sup1):S247-S268.
Score: 0.028
-
Low-contrast response deficits and increased neural noise in children with autism spectrum disorder. Neuropsychologia. 2014 Oct; 63:10-8.
Score: 0.022
-
Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014 May 01; 94(5):677-94.
Score: 0.021
-
Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth. Brain Res. 2014 Sep 11; 1580:188-98.
Score: 0.021
-
Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum Mol Genet. 2012 Nov 01; 21(21):4781-92.
Score: 0.019
-
The effect of diagnosis, age, and symptom severity on cortical surface area in the cingulate cortex and insula in autism spectrum disorders. J Child Neurol. 2013 Jun; 28(6):732-9.
Score: 0.019
-
Brief report: the Autism Mental Status Examination: development of a brief autism-focused exam. J Autism Dev Disord. 2012 Mar; 42(3):455-9.
Score: 0.018
-
A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry. 2012 Mar; 169(3):292-9.
Score: 0.018
-
Advancing paternal age and simplex autism. Autism. 2012 Jul; 16(4):367-80.
Score: 0.018
-
Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study. PLoS One. 2011; 6(11):e28044.
Score: 0.018
-
A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet. 2012 Apr; 131(4):565-79.
Score: 0.018
-
Endocrine disruptors and childhood social impairment. Neurotoxicology. 2011 Mar; 32(2):261-7.
Score: 0.017
-
Analysis of a purported SHANK3 mutation in a boy with autism: clinical impact of rare variant research in neurodevelopmental disabilities. Brain Res. 2011 Mar 22; 1380:98-105.
Score: 0.017
-
Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010 Jul 15; 466(7304):368-72.
Score: 0.016
-
Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology. 2010 Mar; 35(4):990-8.
Score: 0.016
-
Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. Int Clin Psychopharmacol. 2006 Nov; 21(6):363-7.
Score: 0.013
-
Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. J Clin Psychopharmacol. 2006 Aug; 26(4):444-6.
Score: 0.012
-
Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol. 2006 Apr; 9(2):209-13.
Score: 0.012